Utility of isocitrate dehydrogenase 1 as a serum protein biomarker for the early detection of non‐small‐cell lung cancer: A multicenter in vitro diagnostic clinical trial

We aimed to verify the expression status and diagnostic significance of isocitrate dehydrogenase 1 (IDH1) in non‐small‐cell lung cancer (NSCLC), especially during early stages. Serum IDH1 levels were measured by ELISA. A total of 1223 participants (660 patients with NSCLC, 276 healthy controls [HCs]...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Nan, Sun, Shouguo, Gao, Yibo, Li, Yuan, Lu, Zhiliang, Yuan, Zuyang, Che, Yun, Huang, Jianbing, Mao, Shuangshuang, Lei, Yuanyuan, Zang, Ruochuan, Li, Ning, Cui, Wei, Qi, Jun, Chen, Feng, Gao, Jia, Wang, Jinling, Min, Rong, Chen, Yan, Shi, Guangli, Tan, Fengwei, He, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226212/
https://www.ncbi.nlm.nih.gov/pubmed/32167618
http://dx.doi.org/10.1111/cas.14387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226212/
https://www.ncbi.nlm.nih.gov/pubmed/32167618
http://dx.doi.org/10.1111/cas.14387

Ejemplares similares